Transaortic transcatheter aortic valve implantation using edwards sapien valve

Bapat, Vinayak; Khawaja, Muhammed Zeeshan; Attia, Rizwan; Narayana, Ashok; Wilson, Karen M.; Macgillivray, K.; Young, Christopher; Hancock, Jane; Redwood, Simon; Thomas, Martyn

doi:10.1002/ccd.23276

Cited by 142 publications

(94 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The direct transaortic approach for TAVI is a more recently developed alternative to the use of TA access in patients for whom the TF route is contraindicated [10]. In early reports, Clarke et al [11] found good ease of access and visibility using this method, while Lardizabal et al [15] demonstrated superior mortality rates compared to the TA approach, with comparable complication rates.…”

Section: Discussionmentioning

confidence: 99%

“…Still, this route has certain limitations; it is not recommended in patients with chronic lung diseases or poor left ventricular function, and is associated with a risk of serious bleeding complications [7][8][9]. The use of transaortic (TAo) access is a more recently developed alternative to TA-TAVI and TF-TAVI [10,11]. This involves insertion of the catheter via an upper reversed L ministernotomy, which is a safe and well-established procedure in classic cardiac surgery, followed by valve implantation through the ascending aorta.…”

Section: Introductionmentioning

confidence: 99%

“…This approach has been reported to provide ample visibility for the surgeon and fast recovery for most patients [12]. To date, there have been encouraging preliminary results published with regards to TAo-TAVI, however more detailed information is required to assess the true efficacy and safety of the procedure [10]. The material presented herein is taken from the Polish arm of the Registry Of the Utilization of the TAo--TAVI approach using the Edwards SAPIEN Valve (ROUTE).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Transfemoral (TF), transapical and transaortic techniques were performed as previously described. (6)(7)(8) We adopted a 'TF first' approach and only used the transapical route if the TF technique was found to be unsuitable for the patient. There was only one case of transaortic TAVI.…”

Section: Methodsmentioning

confidence: 99%

Mid-term study of transcatheter aortic valve implantation in an Asian population with severe aortic stenosis: two-year Valve Academic Research Consortium-2 outcomes

Chew¹,

Hon²,

Yip³

et al. 2017

smedj

View full text Add to dashboard Cite

INTRODUCTION Transcatheter aortic valve implantation (TAVI) is an effective treatment for high-risk or inoperativepatients with severe aortic stenosis. Given the unique characteristics of Asian populations, questions regarding mid-term outcomes in Asians undergoing TAVI have yet to be addressed. We evaluated the two-year clinical outcomes of TAVI in an Asian population using Valve Academic Research Consortium-2 definitions.METHODS This prospective study recruited 59 patients from a major academic medical centre in Singapore. The main outcomes were two-year survival rates, peri-procedural complications, symptom improvement, valvular function and assessment of learning curve. RESULTSMean age was 76.8 years (61.0% male), mean body surface area 1.6 m 2 and mean logistic EuroSCORE 18.7%. Survival was 93.2%, 86.0% and 79.1% at 30 days, one year and two years, respectively. At 30 days post TAVI, the rate of stroke was 1.7%, life-threatening bleeding 5.1%, acute kidney injury 25.0%, major vascular complication 5.1%, and new permanent pacemaker implantation 6.8%. 29.3% of TAVI patients were rehospitalised (47.1% cardiovascular-related) within one year. These composite outcomes were measured: device success (93.2%); early safety (79.7%); clinical efficacy (66.1%); and time-related valve safety (84.7%). Univariate analysis found these predictors of two-year all-cause mortality: logistic EuroSCORE (hazard ratio [HR] 1.07; p < 0.001); baseline estimated glomerular filtration rate (HR 0.97; p = 0.048); and acute kidney injury (HR 5.33; p = 0.022). Multivariate analysis identified non-transfemoral TAVI as a predictor of cardiovascular-related two-year mortality (HR 14.64; p = 0.008).CONCLUSION Despite the unique clinical differences in Asian populations, this registry demonstrated favourable midterm clinical and safety outcomes in Asians undergoing TAVI.

show abstract

“…[4][5][6] With recent experiences, there were no significant differences in 30 day mortality or procedural complications between transapical approach and transaortic approach. 7 In another study, potential advantages including ease of access and procedure related complication (e.g. false aneurysm, wound pain, respiratory dysfunction) compared with transapical approach were suggested.…”

Section: Discussionmentioning

confidence: 99%

Transcatheter Aortic Valve Implantation Using CoreValve by Transaortic Approach

Park

Shim

et al. 2013

J Lipid Atheroscler

View full text Add to dashboard Cite

This is an Open Access article distributed under the terms of the creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction: Transcatheter aortic valve implantation (TAVI) is now considered as an alternative treatment option for severe aortic stenosis (AS) patients who cannot undergo surgical aortic valve replacement (AVR). Case report: We describe the first Korean case of transaortic TAVI with mini-sternotomy using CoreValve. A 83-year-old woman with severe AS and recent history of non-ST elevation myocardial infarction was referred to our institution for TAVI intervention. There was no amenable peripheral vascular access for transfemoral or trans-subclavian approach. Considering the relatively high procedural risk of transapical approach in this patient, we performed transaortic TAVI with mini-sternotomy. Conclusion:The present case suggests transaortic approach may be an effective and safe strategy for TAVI in high risk severe AS patients without eligible femoral or subclavian access routes.

show abstract

Transaortic transcatheter aortic valve implantation using edwards sapien valve

Abstract: (2017). How should I treat an Edwards SAPIEN 3 aortic valve embolisation during a transaortic transcatheter aortic valve implantation. EuroIntervention, 13(4):495-498.

Cited by 142 publications

References 42 publications

Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry

Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry

Mid-term study of transcatheter aortic valve implantation in an Asian population with severe aortic stenosis: two-year Valve Academic Research Consortium-2 outcomes

Transcatheter Aortic Valve Implantation Using CoreValve by Transaortic Approach

Contact Info

Product

Resources

About